5XV-30499-90335
2 vaccinations
5 coded responses
14 check-ins
5 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 895 / NV
- Registered
- 2021-01-13
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- N/A
Timeline
-
2021-01-13
Registered in v-safe
-
2021-01-13
Dose 1 — Pfizer-BioNTech
- 2021-01-13
- 2021-01-15
- 2021-01-16
-
2021-01-27
Survey response — day 14, dose 1MedDRA: Nasopharyngitis, Respiratory tract congestion, Sinus headache — Feeling: GoodFree text: Cold like symptoms... sinus headache and congestion.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-03
Dose 2 — Pfizer-BioNTech
-
2021-02-04
Survey response — days 1–6 daily, dose 2MedDRA: Palpitations — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to workFree text: Heart palpitations (PVCs and PACs)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-05
- 2021-02-06
- 2021-02-07
- 2021-02-09
- 2021-02-11
-
2021-02-17
Survey response — day 14, dose 2MedDRA: Hypertension — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Consistently high blood pressureMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-26
-
2021-03-10
Survey response — day 35, dose 2MedDRA: Blood pressure increased, C-reactive protein increased, Dyspnoea, Inflammation, Red blood cell sedimentation rate increased, Skin discolouration — Feeling: Fair · Be unable to work, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visitFree text: Elevated CRP and Sedimentation Rate with raised inflammation. Was referred to Rheumatology for a possible new autoimmune disease. Shortness of breath and blood pressure increased. Dark patches in arm pits.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-10
Report sent to call center — day 35, dose 2Be unable to work · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-03-19
Survey response — day 42, dose 2MedDRA: Blood test abnormal, C-reactive protein abnormal, Condition aggravated, Inflammation, Pre-existing disease, Red blood cell sedimentation rate abnormal — Feeling: Fair · Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Worsening high blood pressure. High inflammation discovered by recent blood test, with no indication of infection. Afnormal CRP and Westergren Sed Rate results.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-19
Report sent to call center — day 42, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-10-26
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-13 | Pfizer-BioNTech | |
| 2 | 2021-02-03 | Pfizer-BioNTech |
Call center
2 call center cases
2 unsuccessful
1 wait over 3 months for a first call
Free text
Release 2 — day 14, dose 1
Symptoms: Cold like symptoms... sinus headache and congestion.
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Heart palpitations (PVCs and PACs)
Release 4 — day 14, dose 2
Symptoms: Consistently high blood pressure
Release 5 — day 35, dose 2
Symptoms: Elevated CRP and Sedimentation Rate with raised inflammation. Was referred to Rheumatology for a possible new autoimmune disease. Shortness of breath and blood pressure increased. Dark patches in arm pits.
Release 6 — day 42, dose 2
Symptoms: Worsening high blood pressure. High inflammation discovered by recent blood test, with no indication of infection. Afnormal CRP and Westergren Sed Rate results.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Blood pressure increased | ✓ | ✓ | ✓ |
| SD | Blood test abnormal | ✓ | ✓ | ✓ |
| SD | C-reactive protein abnormal | ✓ | ✓ | ✓ |
| SD | C-reactive protein increased | ✓ | ✓ | ✓ |
| SD | Condition aggravated | ✓ | ✓ | ✓ |
| SD | Dyspnoea | ✓ | ✓ | ✓ |
| SD | Hypertension | ✓ | ✓ | ✓ |
| SD | Inflammation | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Red blood cell sedimentation rate abnormal | ✓ | ✓ | ✓ |
| SD | Red blood cell sedimentation rate increased | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SD | Sinus headache | ✓ | ✓ | ✓ |
| SD | Skin discolouration | ✓ | ✓ | ✓ |
| SRO | Palpitations | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release